Navigation Links
Carnegie Mellon develops computer model to study cell membrane dynamics
Date:4/8/2008

ttles, a cell couldnt survive.

Ultimately, understanding the dynamics of vesiculation is key to advancing the design of anti-viral therapies or understanding how protein processing goes awry within a cell and leads to disease, Deserno said.

Deserno and his team created a computer simulation of a cell membrane with a lipid bilayer a soap-like film made of 50,000 individual lipids molecules and studded it with 36 evenly spaced and contact lens-shaped disks representing remodeling proteins, which are involved in vesiculation. Then he set the simulation to allow the fluid membrane to fluctuate as it normally would. During the simulation, the artificial membrane began curving in places. In creating curved membrane structures, each disk bent the membrane slightly. This local curvature spread around a disk like a little halo. When two disks approached one another, the overlapping halos led to an indirect interaction. Thus, while there was no explicit interaction between the disks, these objects indirectly attracted each other via the membrane, Desernos group found.

With this work, we provide solid support for a mechanism that has been gaining in popularity recently, Deserno said. To date, no one has demonstrated at the biophysical level exactly what most people have come to accept as evident that remodeling proteins can indeed aggregate and facilitate vesiculation based on their curvature imprint alone. Our simulations show that proteins need not interact directly to drive this critical process.

Understanding how vesiculation physically operates should make it easier in the long run to rationally design and deliver drugs to individual cells, according to Deserno. This is the biggest practical value of our research. Now that we have a proposed mechanism, we can subject it to well-posed questions, such as why certain proteins are always present during vesiculation.

In addition to investigating the pr
'/>"/>

Contact: Jocelyn Duffy
jhduffy@andrew.cmu.edu
412-268-9982
Carnegie Mellon University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
2. Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing
3. Carnegie Mellon scientist uses mass spectrometer to weigh virus particle, von Willebrand factor
4. Carnegie Mellon, Pitt Team to study psychosocial stress
5. Mellon awards Carnegie Grant for Ecological Monitoring in South Africa
6. Carnegie Mellon researchers to develop new drug delivery system
7. Carnegie Mellon students win contest
8. Novel mechanism for long-term learning identified by Carnegie Mellon researchers
9. U. Mass Medical School and Carnegie announce licensing agreements with Oxford BioMedica
10. Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design
11. Carnegie Mellon receives $1.85 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... A coating on windows or solar panels that repels ... next electric car? New Tel Aviv University research, just ... in assembling peptides at the nano-scale level that could ... few years. , Operating in the range of 100 ...
(Date:12/3/2009)... in warmer water, according to an intriguing new study suggesting ... Experiments with two species of young damselfish on Australia,s Great ... reef fish are either consistently timid, or consistently bold, and ... temperatures rise. , A slight lift of just one or ...
(Date:12/3/2009)... scientists from the U.S. Department of Energy,s (DOE) Brookhaven ... Science has made a major step in understanding how ... necessary to carry out important biological processes. The research, ... Nature Structural & Molecular Biology , confirms that many ...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Managed Health Services Partners With Milwaukee Health Services to Increase Access to Care for Underserved Communities 48218 1Managed Health Services Partners With Milwaukee Health Services to Increase Access to Care for Underserved Communities 48218 2Managed Health Services Partners With Milwaukee Health Services to Increase Access to Care for Underserved Communities 48218 3PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 1PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 2PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 3PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 4PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 5PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 6Caliper Life Sciences to Webcast Investor Session of Open House 12528 1Caliper Life Sciences to Webcast Investor Session of Open House 12528 2
... in his lab. Millions of people the world over ... that has yet provided a universally accepted solution. However, a ... has come up with a practical weight loss solution for ... , For this development, Yaniv Linde, a 32-year-old Ph.D. ...
... of the University of Pennsylvania have found that deleting a ... loss of stem cell reservoirs in adult mice. This gene, ... and mutations in proteins in the DNA damage response underlie ... work appears in the inaugural issue of Cell Stem Cell. ...
... N.Y. – Cold Spring Harbor Laboratory (CSHL) researchers led ... Hughes Medical Investigator (HHMI) Greg Hannon have identified a ... tumor suppressor network, called the p53 pathway, to fight ... on several fronts to understand the p53 pathway because ...
Other Biology News:How to lose weight and not go hungry: HU researcher develops drug that mimics feeling of 'fullness' 2Loss of stem cells correlates with premature aging in animal study 2Study shows big power of small RNAs, not just proteins, in halting cancer 2
(Date:12/6/2009)... Boehringer Ingelheim today announced results from the RE-COVER(TM) ... direct thrombin inhibitor (DTI),(2) compared to dose-adjusted warfarin ... the trial were presented at the 51st American ... online in the New England Journal of ... primary outcome of the trial, six month incidence ...
(Date:12/4/2009)... Alberta Centre for Advanced Micro Nano Technology Products ... seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ... how technologies like nanotechnology, biomaterials and microfluidics can ... innovative healthcare products that help promote health and ...
(Date:12/3/2009)... Houston, LLC announced today that it has updated ... vertical sleeve gastrectomy , along with the ... sleeve gastrectomy procedure at the facility was performed by ... October 20, 2009. The patient is reported as doing ...
(Date:12/3/2009)... FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: ... of compounds for the treatment of cardiovascular and metabolic ... patient visit in its Phase 2 FDG-PET clinical trial ... patients and was carried out at five sites in ...
Breaking Biology Technology:RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6Alberta companies delivering new products to the health & medical marketplace 2JourneyLite of Houston Now Offering Sleeve Gastrectomy 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) a biopharmaceutical ... candidates for the treatment,of cancer and infectious diseases, ... officer, is scheduled to present at the 2007,Thomas ... at 1:30 p.m. Eastern Daylight Time. The conference ...
... - ... ... PDL BioPharma, Inc.,(PDL) (Nasdaq: PDLI ) today announced a ... of novel antibodies in,oncology and select immunological diseases, following a months-long,business ...
... Aug. 28 The American Chemical Society,(ACS) presented the ... prestigious 2007 Heroes of Chemistry award this week,at the ... new 100,percent renewable ingredient -- the first of its ... Tenn., by the DuPont Tate & Lyle Bio,Products joint ...
Other Biology Technology:ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference 2PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 2PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 3PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 4PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 5DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM) 2DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM) 3DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM) 4
... 2 Detection System combines the indirect ... principle and Signets unique formulation of ... and reliablility. Signet reagents will achieve ... and automated protocols. ,Signets USA ...
Each bottle contains: Bromophenol Blue 0.25% w/v , Xylene Cyanol FF 0.25%, Glycerol solution 30% w/v...
XEDAR Antibody...
Rabbit Anti-JNK1/SAPK pan, Polyclonal Antibody...
Biology Products: